A comparison of clinical pharmacist management of type 2 diabetes versus usual care in a federally qualified health center | Zendy

Rhianna M Fink | Zendy; Emanuela V. Mooney | Zendy; Joseph J. Saseen | Zendy; Sarah J. Billups | Zendy

Open Access

A comparison of clinical pharmacist management of type 2 diabetes versus usual care in a federally qualified health center

Author(s) -

Rhianna M Fink,

Emanuela V. Mooney,

Joseph J. Saseen,

Sarah J. Billups

Publication year - 2019

Publication title -

pharmacy practice

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.608

H-Index - 24

eISSN - 1886-3655

pISSN - 1885-642X

DOI - 10.18549/pharmpract.2019.4.1618

Subject(s) - medicine , pharmacist , clinical pharmacy , type 2 diabetes , glycemic , diabetes mellitus , metformin , medication therapy management , pharmacotherapy , pharmacy , cohort , retrospective cohort study , health care , diabetes management , insulin , family medicine , endocrinology , economic growth , economics

Pharmacotherapy approaches to managing patients with uncontrolled type 2 diabetes varied between clinical pharmacists and other clinician providers. For patients already on basal insulin, clinical pharmacists were more likely to intensify therapy with the addition of non-basal insulin, including more frequent initiation of prandial insulin and by adding newer antihyperglycemic agents.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research